Aptalis Pharma is a biotechnology startup founded in 1982. The company received a $170.47K Seed Round investment on 02 September 2011. Although headquartered details are not provided, the startup operates within the pharmaceutical industry and is under the umbrella of Allergan plc (NYSE: AGN), a global pharmaceutical company based in Dublin, Ireland. With an extensive history and a focus on biotechnology, Aptalis Pharma presents an intriguing opportunity for venture capital investment.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $170.47K | - | 02 Sep 2011 |
We care about your data, and we'd love to use cookies make your experience better.
